ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT (ALLO-HSCT)

Clinical trials for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT (ALLO-HSCT) explained in plain language.

Never miss a new study

Get alerted when new ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT (ALLO-HSCT) trials appear

Sign up with your email to follow new studies for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT (ALLO-HSCT), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Could a feeding tube after transplant prevent dangerous gut problems?

Disease control Not yet recruiting

This study is testing if starting liquid nutrition through a feeding tube right after a stem cell transplant is better than the standard approach of waiting until eating becomes difficult. It aims to see if this early nutrition can reduce severe gut inflammation, help patients ma…

Matched conditions: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT (ALLO-HSCT)

Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Disease control

Last updated Mar 30, 2026 14:32 UTC

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT (ALLO-HSCT)

Get alerted when new ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT (ALLO-HSCT) trials appear

Could a feeding tube after transplant prevent dangerous gut problems?